Evidence map›Paper›PMID 40042895›Full record

ArticleGM crops & food2025

Assessment of interspecies and intergeneric gene flow for the GM

Kasthurirengan Sampath, Zhang Shilu, Hong Yan, Yogendra Kr Tripathi, Srinivasan Ramachandran

Abstract read
In one paragraph

Article in GM crops & food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. AssessingFrontiers in plant science · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kasthurirengan SampathTemasek Lifesciences Laboratory, 1 Research Link, National University of Singapore, Singapore.
Zhang ShiluTemasek Lifesciences Laboratory, 1 Research Link, National University of Singapore, Singapore.
Hong YanJOil (S) Pte Ltd, 1 Research Link, National University of Singapore, Singapore.
Yogendra Kr TripathiTemasek Lifesciences Laboratory, 1 Research Link, National University of Singapore, Singapore.
Srinivasan RamachandranTemasek Lifesciences Laboratory, 1 Research Link, National University of Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GM Jatropha X8#34 was placed for transgene flow assessment in the open field trial on Semakau Island, Singapore, between 2015 and 2017 to evaluate the potential gene flow to its non-GM counterparts and related species. The trial featured the GM Jatropha event X8#34, which is characterized by high oleic acid content, marker-free, and a homozygous transgene. The study focused on cross-pollination from the GM event to non-GM plants, analyzing factors such as distance, wind and insects mediated transfer, using event-specific multiplex PCR analysis of F1 seeds. Pollen dispersal by wind was also assessed to understand the extent of distance traveled and pollen load. Our results showed the maximum observed transgene flow was 4.5%, occurring in non-GM plants located 2 meters in third quarter of 2016, average for four quarters is 2.57%. However, as the distance increased, the transgene flow decreased significantly, at 4 meters distance observed 0.8% in fourth quarter and an average 0.25%. Transgene flow was not observed beyond 4 meters. These results are consistent with the exponential decrease in Jatropha pollen dispersed and captured by traps over distance, with no pollen detected beyond 6 meters through wind dispersal. Furthermore, no intrageneric transgene flow was detected from GM Jatropha to

Indexed as

Gene FlowJatrophaOleic AcidPlants, Genetically ModifiedSeedsPollenPollinationTransgenesOleic AcidInterspeciesnon-GM Jatrophaoutcrosstransgene flow, spatial isolation, pollen load

Identifiers

PMID40042895
PMCPMC11901391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.